Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP015K (peficitinib) Phase 2b in Moderate to Severe Rheumatoid Arthritis
NCT01649999Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Mar 2012; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01649999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01649999.